The Invesco S&P International Developed Quality ETF (IDHQ), a smart beta fund tracking the S&P Quality Developed ex US LargeMidCap Index, has amassed over $462.27 million and stands out with the lowest expense ratio in its category at 0.29%. Launched in 2007, IDHQ has demonstrated robust performance, gaining 18.02% year-to-date and 10.3% over the last 12 months (as of 06/30/2025), while maintaining a low-risk profile with a beta of 0.89. This positions IDHQ as a significant, cost-efficient, and relatively low-risk vehicle for institutional investors seeking exposure to quality international developed market equities.
The Invesco S&P International Developed Quality ETF (IDHQ) is positioned as a cost-effective and lower-risk vehicle for exposure to developed ex-US large and mid-cap equities. The fund's smart beta strategy, which screens for high-quality companies based on return on equity, accruals, and financial leverage, has yielded strong results, with an 18.02% year-to-date gain and a 10.3% return over the last 12 months as of June 30, 2025. A key competitive advantage is its 0.29% expense ratio, cited as the lowest in its category and significantly below alternatives like FICS (0.70%) and PIZ (0.80%). With over $462 million in assets, IDHQ has achieved significant scale. Its risk profile is favorable, showing lower volatility than the broader market with a beta of 0.89 and a standard deviation of 16.28%. While the fund is well-diversified across 204 holdings, there is a notable concentration, with the top 10 holdings, including Novartis and ASML, accounting for 34.01% of total assets. The fund also offers a 2.29% trailing dividend yield, adding an income component to its proposition.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.65
Ticker Sentiment